Enodia Therapeutics is a biotech company that provides transforming treatments for cancer, inflammation, and viral infection diseases.
Enodia Therapeutics has raised $24.2M in total funding. The most recent round was Seed. The last funding was announced in January 2026.
Enodia Therapeutics's investors include Bpifrance, Pfizer Venture Investments, Mission BioCapital, Pasteur Institute, Elaia.
Enodia Therapeutics is headquartered in Paris, France.
Enodia Therapeutics is a biotech company that provides transforming treatments for cancer, inflammation, and viral infection diseases.
Enodia Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Enodia Therapeutics — Funding & Investors." VCBacked, January 8, 2026, https://www.vcbacked.co/company/enodia-therapeutics. Accessed August 1, 2026.
VCBacked. (2026). Enodia Therapeutics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/enodia-therapeutics
{{cite web |title=Enodia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/enodia-therapeutics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated